This Month
Nearly half of Australians chronically sick
A surge in mental health diagnoses has pushed the number of people with chronic conditions to the highest level since records began.
- Euan Black
Inside the Chemist Warehouse franchisee world
There are over 200 managing partners who are shareholders in the discount chain. They are all ambitious pharmacy owners, many with multiple sites.
- Carrie LaFrenz
ACL pulls Healius bid as ACCC blocks pathology shake-up
Australian Clinical Labs, the No.3 player in the pathology market, has not given up in its chase for ailing No.2 player Healius.
- Simon Evans
- Opinion
- Chanticleer
Brian Hartzer’s warning to AI wannabes
The former Westpac boss, who is now CEO of Quantium Health, says effective AI use for companies is all about balance.
- Updated
- James Thomson
Eight tips to survive Christmas if you’ve stopped drinking
The holidays can be incredibly difficult to navigate if you’ve decided to give up alcohol. Here’s what a sobriety expert recommends.
- Richard Piper
Men’s health player Mosh appoints adviser to explore exit options
Gavin Jacobson’s advisory firm has won the sell-side mandate to explore options for Mosh.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Sigma could shed customers after Chemist Warehouse merger
The deal, creating an $8.8 billion retail and wholesaling giant, could even be blocked by competition regulators, according to analysts at Morningstar.
- Carrie LaFrenz and Tom Richardson
NDIS overhaul to weed out profiteers and price gougers
The long-awaited review of the disability scheme demands higher standards of service providers and recommends measures to eradicate overservicing and fraud.
- Phillip Coorey and Michael Read
- Opinion
- Chanticleer
Why the $8b Chemist Warehouse deal is historic and creative
Chemist Warehouse founders Jack Gance and Mario Verrocchi and HMC boss David Di Pilla have cooked up an unorthodox way to finally get the retail giant onto the ASX boards.
- James Thomson
Medibank Private secures binding deal to lift Myhealth stake
It is understood the listed insurer will go from owning about 33.3 per cent of the GP clinics chain to 66.66 per cent at a $260 million valuation.
- Sarah Thompson, Kanika Sood and Emma Rapaport
‘Fraudulent’: NDIS firm quotes $40k for ramp that cost $11k
Unscrupulous NDIS providers are seeking to take advantage of the scheme’s vague promise to provide care that is ‘reasonable and necessary’.
- Updated
- Gus McCubbing
Why it’s so hard to make money from blood tests
There’s restructuring ahead at the No. 2 pathology provider Healius, which despite its activist ructions, has yielded a 30 per cent return since its 2023 low.
- Simon Evans
November
Integral Diagnostics chair pops up for Partners Group at Cura auction
The Zug-headquartered private equity firm is serious about its tilt as it jostles with Intermediate Capital Group and a Medibank/Macquarie consortium.
- Sarah Thompson, Kanika Sood and Emma Rapaport
This moonshot tech firm is Australia’s fastest growing company
Fleet Space Technologies, with a compound annual growth rate of 582 per cent over three years, is top of the Fast 100 class for 2023.
- Michael Bailey
Meet the Fast Starters building healthcare empires
Health companies make up about 10 per cent of this year’s list, reflecting demand for better, cheaper and more convenient access to products and services.
- Ronald Mizen
Sexual health and fertility details leaked in ACL data breach
ASX-listed pathology provider Australian Clinical Labs faces potentially millions of dollars in fines for failing to protect sensitive financial and health data.
- Paul Smith
Healius chairwoman exits without apology for $2b wipeout
Departing Healius chairwoman Jenny Macdonald understands shareholder “frustration” but would not apologise for $2b of value destruction.
- Simon Evans
- Opinion
- Chanticleer
Healius chair’s head on a stick shows investors out of patience
If the healthcare company can’t pull up its socks in the medium term, expect investors to push the board to think about other ways to realise value.
- Anthony Macdonald
How the tech crowd track their health to live longer
‘Quantified self’ is a movement where the health conscious are trying to leave nothing to chance, using the latest in technology to monitor their bodies and fitness.
- Nick Bonyhady
Final bids for $500 million-plus Cura auction; doctors weigh in
Intermediate Capital Group, Partners Group and Macquarie Capital-advised Medibank are jostling for the doctor-owned day surgery network.
- Sarah Thompson, Kanika Sood and Emma Rapaport